CN103910685A - Method used for purifying sulfadimoxine - Google Patents

Method used for purifying sulfadimoxine Download PDF

Info

Publication number
CN103910685A
CN103910685A CN201410083160.7A CN201410083160A CN103910685A CN 103910685 A CN103910685 A CN 103910685A CN 201410083160 A CN201410083160 A CN 201410083160A CN 103910685 A CN103910685 A CN 103910685A
Authority
CN
China
Prior art keywords
sulphormethoxine
filtrate
acid solution
sulfadimoxine
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410083160.7A
Other languages
Chinese (zh)
Inventor
邵香民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changshu Nanhu Industrial Chemical Co Ltd
Original Assignee
Changshu Nanhu Industrial Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changshu Nanhu Industrial Chemical Co Ltd filed Critical Changshu Nanhu Industrial Chemical Co Ltd
Priority to CN201410083160.7A priority Critical patent/CN103910685A/en
Publication of CN103910685A publication Critical patent/CN103910685A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines

Abstract

The invention relates to a method used for purifying sulfadimoxine. The method comprises following steps: (a) deionized water and calcium hydrate are delivered into a reaction container, an obtained mixture is heated to 80 to 85 DEG C, a sulfadimoxine coarse product is added with stirring, and pH value is adjusted to 9.5 to 10.5 so as to realize complete dissolving; (b) active carbon is delivered into the reaction container, an obtained mixed material is stirred for 0.5 to 2h at a temperature of 80 to 85 DEG C, and a filtrate is obtained via filtration; and (c) gracial acetate acid solution is added dropwise into the filtrate at a temperature of 75 to 80 DEG C, and then an obtained material is cooled via ice-water bath, pH value is adjusted to 5.1 to 5.4, the material is allowed to stand, and is subjected to centrifugal dewatering after precipitation, and a filter residue is collected. According to the method, gracial acetate acid solution is added dropwise into the filtrate, the obtained material is allowed to stand for precipitation, and is cooled via ice-water bath, so that sulfadimoxine can be precipitated rapidly, influences caused by other impurities are avoided, and purity and yield of sulfadimoxine are increased.

Description

A kind of method of the sulphormethoxine of purifying
Technical field
The present invention relates to a kind of preparation method of sulphormethoxine, be specifically related to a kind of method of the sulphormethoxine of purifying.
Background technology
Sulphormethoxine, chemistry 4-(p-amino benzene sulfonyl)-5 by name, 6-dimethoxypyridin, be generally used for the treatment of inflammation, as upper respiratory tract infection tonsillitis, bacillary dysentery enteritis, skin infections etc., also can coordinate with other drug, be used for the treatment of pulmonary tuberculosis, lymphoid tuberculosis.Sulphormethoxine has experienced several generations' research and development, and its production technique is progressively stable, is specially following preparation process:
Step (1):
Step (2):
Step (3):
Step (4):
Step (5):
Granted publication number is the method for purification that the Chinese invention patent of CN102304095B discloses a kind of sulphormethoxine, utilizes and adds respectively the adjusting such as calcium hydroxide, Glacial acetic acid pH that it is separated out in sulphormethoxine solution.Although aforesaid method can improve the purity of sulphormethoxine, be wherein still mixed with more impurity.For medicine intermediate field, its purity requirement to sulphormethoxine is higher, otherwise people is known from experience and produces immeasurable impact.
Summary of the invention
The present invention seeks to provide in order to overcome the deficiencies in the prior art a kind of method of the sulphormethoxine of purifying.
For achieving the above object, the technical solution used in the present invention is: a kind of method of the sulphormethoxine of purifying, comprise the following steps successively,
(a) in reaction vessel, add deionized water and calcium hydroxide, be heated to 80~85 ℃, under agitation condition, add subsequently the thick product of sulphormethoxine, then regulate pH to 9.5~10.5, it is all dissolved;
(b) in container, add gac, filter to get filtrate stir 0.5~2 hour under 80~85 ℃ of conditions after;
(c) under 75~80 ℃ of conditions, in described filtrate, drip glacial acetic acid solution, regulate pH to 5.1~5.4, staticly settle rear centrifuge dehydration and get filter residue; In step (c), it is cooling that described glacial acetic acid solution is placed in ice-water bath by filtrate after dripping.
Optimally, it also comprises that step (d) is placed in described filter residue at 100~120 ℃ and is dried 2~6 hours.
Optimally, in step (a), described calcium hydroxide at least divides three times and adds.
Optimally, the mass concentration of described glacial acetic acid solution is 25~20%.
Further, in step (d), after described filter residue and drying, be cooled to 45 ℃ with bottom discharge.
Because technique scheme is used, the present invention compared with prior art has following advantages: the purify method of sulphormethoxine of the present invention, cooling by filtrate being placed in to ice-water bath in the time that dropping glacial acetic acid solution staticly settles, can make sulphormethoxine precipitate rapidly, can get rid of the interference of other composition, improve purity and the productive rate of sulphormethoxine.
Embodiment
The purify method of sulphormethoxine of the present invention, comprises the following steps successively, (a) in reaction vessel, adds deionized water and calcium hydroxide, be heated to 80~85 ℃, under agitation condition, add subsequently the thick product of sulphormethoxine, then regulate pH to 9.5~10.5, it is all dissolved; (b) in container, add gac, filter to get filtrate stir 0.5~2 hour under 80~85 ℃ of conditions after; (c) under 75~80 ℃ of conditions, in described filtrate, drip glacial acetic acid solution, regulate pH to 5.1~5.4, staticly settle rear centrifuge dehydration and get filter residue; In step (c), it is cooling that described glacial acetic acid solution is placed in ice-water bath by filtrate after dripping.Cooling by filtrate being placed in to ice-water bath in the time that dropping glacial acetic acid solution staticly settles, can make sulphormethoxine precipitate rapidly, can get rid of the interference of other composition, improve purity and the productive rate of sulphormethoxine.
In order to get rid of the impact of moisture on sulphormethoxine, after step (c), also should comprise: step (d) is placed in described filter residue at 100~120 ℃ and is dried 2~6 hours, thoroughly removes moisture, should be cooled to subsequently 45 ℃ with bottom discharge.Because calcium hydroxide is slightly soluble in water, and in dissolution process, discharge a large amount of heats, it should at least divide and add for three times, and controls temperature and be no more than 80 degrees Celsius.The mass concentration of glacial acetic acid solution is preferably 25~20%, can not be too dense, otherwise be difficult to system pH to be controlled in 5.1~5.4.
Below in conjunction with specific embodiment, the present invention is described in more detail:
Embodiment 1
This example provides a kind of method of the sulphormethoxine of purifying, and concrete charge ratio is as shown in table 1:
Table 1 reaction raw materials and charge ratio thereof
Material name Charging capacity (kg) Molecular weight Remarks
The thick product of sulphormethoxine Complete batch 310.33 ?
Deionized water 2400 18 ?
Calcium hydroxide 20 74.08 ?
Gac 12.5 12 ?
Glacial acetic acid 35 60 ?
Specific operation process is as follows:
(a) in reaction vessel, add deionized water and calcium hydroxide, be heated to 80~85 ℃, under agitation condition, add subsequently the thick product of sulphormethoxine, then regulate pH to 9.5~10.5, the thick product of sulphormethoxine is all dissolved;
(b) in container, add gac, under 80~85 ℃ of conditions, stir after 1 hour, have the monolithic Filter Press of two metafiltration cloth one deck filter paper to obtain filtrate by pin it;
(c) under 75~80 ℃ of conditions to the glacial acetic acid solution that drips 25~30wt% in described filtrate, regulate pH to 5.1~5.4, be placed in ice-water bath cooling, staticly settle 5~15 minutes after centrifuge dehydration get filter residue;
(d) described filter residue is placed at 100~120 ℃ and is dried 4 hours, be cooled to 45 ℃ with bottom discharge.
Above-described embodiment is only explanation technical conceive of the present invention and feature; its object is to allow person skilled in the art can understand content of the present invention and implement according to this; can not limit the scope of the invention with this; all equivalences that spirit is done according to the present invention change or modify, within all should being encompassed in protection scope of the present invention.

Claims (5)

1. the purify method of sulphormethoxine, comprises the following steps successively,
(a) in reaction vessel, add deionized water and calcium hydroxide, be heated to 80~85 ℃, under agitation condition, add subsequently the thick product of sulphormethoxine, then regulate pH to 9.5~10.5, it is all dissolved;
(b) in container, add gac, filter to get filtrate stir 0.5~2 hour under 80~85 ℃ of conditions after;
(c) under 75~80 ℃ of conditions, in described filtrate, drip glacial acetic acid solution, regulate pH to 5.1~5.4, staticly settle rear centrifuge dehydration and get filter residue;
It is characterized in that: in step (c), it is cooling that described glacial acetic acid solution is placed in ice-water bath by filtrate after dripping.
2. the method for purification sulphormethoxine according to claim 1, is characterized in that: it also comprises that step (d) is placed in described filter residue at 100~120 ℃ and is dried 2~6 hours.
3. the method for purification sulphormethoxine according to claim 1, is characterized in that: in step (a), described calcium hydroxide at least divides three times and adds.
4. the method for purification sulphormethoxine according to claim 1, is characterized in that: the mass concentration of described glacial acetic acid solution is 25~20%.
5. the method for purification sulphormethoxine according to claim 2, is characterized in that: in step (d), be cooled to 45 ℃ with bottom discharge after described filter residue and drying.
CN201410083160.7A 2014-03-10 2014-03-10 Method used for purifying sulfadimoxine Pending CN103910685A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410083160.7A CN103910685A (en) 2014-03-10 2014-03-10 Method used for purifying sulfadimoxine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410083160.7A CN103910685A (en) 2014-03-10 2014-03-10 Method used for purifying sulfadimoxine

Publications (1)

Publication Number Publication Date
CN103910685A true CN103910685A (en) 2014-07-09

Family

ID=51036736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410083160.7A Pending CN103910685A (en) 2014-03-10 2014-03-10 Method used for purifying sulfadimoxine

Country Status (1)

Country Link
CN (1) CN103910685A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557736A (en) * 2014-12-13 2015-04-29 常熟市金申医化制品有限责任公司 Purification method of sulfadoxine
CN104557735A (en) * 2014-12-04 2015-04-29 重庆康乐制药有限公司 Preparation method of high-purity sulfadoxine
CN112592319A (en) * 2020-12-22 2021-04-02 重庆康乐制药有限公司 Refining method of high-quality sulfadoxine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO63267A2 (en) * 1974-01-09 1978-02-20 Medicamente Intreprinderea De PROCESS FOR OBTAINING 4,6-DIHYDROXY-5-METHOXYPYRIMIDINE
CN1569843A (en) * 2004-04-29 2005-01-26 常熟市南湖实业化工厂 Preparation method for sulfadoxine
CN102304095A (en) * 2011-09-23 2012-01-04 常熟市南湖实业化工有限公司 Preparation method of sulfadoxine
CN102391190A (en) * 2011-09-30 2012-03-28 常熟市金申医化制品有限责任公司 Method for preparing sulfadoxine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO63267A2 (en) * 1974-01-09 1978-02-20 Medicamente Intreprinderea De PROCESS FOR OBTAINING 4,6-DIHYDROXY-5-METHOXYPYRIMIDINE
CN1569843A (en) * 2004-04-29 2005-01-26 常熟市南湖实业化工厂 Preparation method for sulfadoxine
CN102304095A (en) * 2011-09-23 2012-01-04 常熟市南湖实业化工有限公司 Preparation method of sulfadoxine
CN102391190A (en) * 2011-09-30 2012-03-28 常熟市金申医化制品有限责任公司 Method for preparing sulfadoxine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
上海第二制药厂: "4-磺胺-5 , 6-二甲氧基嘧啶(周效磺胺) 的合成", 《医药工业》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557735A (en) * 2014-12-04 2015-04-29 重庆康乐制药有限公司 Preparation method of high-purity sulfadoxine
CN104557735B (en) * 2014-12-04 2017-03-22 重庆康乐制药有限公司 Preparation method of sulfadoxine
CN104557736A (en) * 2014-12-13 2015-04-29 常熟市金申医化制品有限责任公司 Purification method of sulfadoxine
CN112592319A (en) * 2020-12-22 2021-04-02 重庆康乐制药有限公司 Refining method of high-quality sulfadoxine

Similar Documents

Publication Publication Date Title
CN106631974B (en) The method for preparing Indobufen
CN102391190A (en) Method for preparing sulfadoxine
CN103910685A (en) Method used for purifying sulfadimoxine
CN103102294A (en) Production method carboxymethyl cysteine
CN106336396A (en) Alogliptin benzoate preparation method
CN103275150A (en) Method for refining and preparing erythromycin thiocyanate
CN111087326A (en) Method for refining guanidine nitrate
CN103360513A (en) Production method for colloidal pectin bismuth
CN102399200A (en) Suspension crystallization method for preparing crystal form I of linezolid
CN101983965B (en) Method of finely extracting ursolic acid from haw
CN102153479B (en) Recovering and applying method of triethylamine in acylation liquid for preparing levofloxacin 1
CN104326954B (en) A kind of synthetic method of Fudosteine
CN106146560A (en) A kind of process for purification of high-purity phosphoric acid specially azoles amine
CN105566098A (en) Method for combined production of high purity crystalline calcium acetate and waterless calcium acetate
CN105622474A (en) Production technique of fudosteine
CN107304186A (en) A kind of process for purification of olaparib
CN102838586A (en) Method for preparing lenalidomide
CN108299538B (en) Method for removing isoursodesoxycholic acid in duck bile
CN112552283A (en) Preparation method of novel tinib medicine
CN110862429A (en) Preparation method of sodium aescinate
CN102206185B (en) Process for refining bendazac lysine and analogs thereof
CN105753733A (en) AHU377 crystal form and preparation method and uses thereof
CN106986864B (en) Preparation device and preparation method of azithromycin
CN104513251A (en) Nalmefene hydrochloride preparation method
CN105294577B (en) A kind of preparation method of the methoxy pyrimidine of sulfanilamide (SN) 6

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140709